4 Analysts Have This To Say About Agios Pharmaceuticals
4 Analysts Have This To Say About Agios Pharmaceuticals
4位分析師對agios pharmaceuticals發表了看法
The standing of Agios Pharmaceuticals among financial...In the latest quarter, 4 analysts provided ratings for Agios Pharmaceuticals (NASDAQ:AGIO), showcasing a mix of bullish and bearish perspectives.
在最新的一個季度中，有4位分析師爲Agios Pharmaceuticals（納斯達克:AGIO）提供了評級，展示了看好和看淡的不同觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
Analysts have recently evaluated Agios Pharmaceuticals and provided 12-month price targets. The average target is $54.25, accompanied by a high estimate of $56.00 and a low estimate of $51.00. A decline of 3.12% from the prior average price target is evident in the current average.
分析師最近對agios pharmaceuticals進行了評估，並提供了12個月的目標價格。平均目標價爲54.25美元，高估值爲56.00美元，低估值爲51.00美元。當前的平均目標價格顯示與之前的平均目標價格相比下降了3.12%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The standing of Agios Pharmaceuticals among financial...
通過對最近分析...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間